This program is supported by an independent educational grant from Bristol Myers Squibb (BMS).
This online education program has been designed solely for healthcare professionals in the USA. The content is not available for healthcare professionals in any other country.
Join pulmonary fibrosis expert Dr. Corey Kershaw for this accredited, free online teaching session exploring the latest evidence and advances in idiopathic and progressive pulmonary fibrosis (IPF and PPF), through an interactive case-based teaching session.
Accreditation: 0.75 AMA PRA Category 1 Credits™
Session Overview
- Recognizing Early PF and Accelerating Diagnosis. Identify subtle HRCT changes and early clinical features to improve timely diagnosis and minimize delays in evaluation.
- Decoding Molecular Pathways Driving PF. Understand the roles of LPA/LPAR1, PDE4B, and prostacyclin pathways in fibrosis progression—and their emerging therapeutic implications.
- Optimizing Therapy and Supporting Persistence. Address real-world challenges in antifibrotic therapy initiation, adherence, and tolerability through practical, patient-centered approaches.
- Evaluating Emerging Evidence. Interpret recent clinical trial data and explore multi-pathway therapies poised to transform pulmonary fibrosis care.
Who Should Attend?
This program is for healthcare professionals in the USA only:
- Pulmonologists
- Radiologists
- Pathologists
- Nurse Practitioners
- Physician Assistants
- Respiratory Therapists
- Pharmacists
- Nurses and other HCPs involved in PF care
Faculty
Dr. Corey Kershaw, M.D. is a Professor at the Department of Internal Medicine UT Southwestern Medical Center. Dr. Kershaw is Clinical Services Chief for the Division of Pulmonary and Critical Care Medicine at UT Southwestern, specializing in interstitial lung diseases. He earned his medical degree from the University of Texas–Houston and completed his residency and fellowship at Emory University. Board-certified in pulmonary and critical care medicine, Dr. Kershaw leads clinical research in idiopathic pulmonary fibrosis and related interstitial lung diseases, contributing to multiple industry-funded trials advancing PF therapies.
Continuing Education Information
This continuing education activity will be provided by Current Concepts Institute (CCI) and MedAll. Physicians, Nurse Practitioners, and Physician Assistants will be eligible for AMA PRA Category 1 Credit™; Nurses for ANCC Contact Hours. Pharmacists will be eligible for ACPE credit. A statement of participation is available for other healthcare professionals.
Unapproved and/or off-label use disclosure
Current Concepts Institute/MedAll requires CE faculty to disclose to the participants:
1. When products or procedures being discussed are off-label, unlabelled, experimental, and/or investigational (not US Food and Drug Administration [FDA] approved); and
2. Any limitations on the information presented, such as data that are preliminary or that represent ongoing research, interim analyses, and/or unsupported opinion.
Disclosures
Below is a listing of all individuals who are involved in the planning and implementation of this accredited continuing education activity. All relevant financial relationships listed for these individuals have been mitigated.
Dr. Corey Kershaw has disclosed financial relationships within the past 24 months with the following ineligible companies: Boehringer Ingelheim, in an advisory board role. These disclosures are made in accordance with ACCME standards to ensure transparency and objectivity in continuing education. Dr. Kershaw does not intend to reference any unlabeled or unapproved uses of products during the presentation.
CCI staff, MedAll staff, and all planners and reviewers have no relevant financial relationships with ineligible companies to disclose.
Activity Accreditation for Health Professions
Physicians
AMA PRA Category 1 Credits™ are available for this activity.
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Current Concepts Institute and MedAll Education. Current Concepts Institute is accredited by the ACCME to provide continuing medical education for physicians.
Current Concepts Institute designates this online activity a maximum of 0.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Other Professionals
All other health care professionals completing this continuing education activity will be issued a statement of participation indicating the number of hours of continuing education credit. This may be used for professional education CE credit. Please consult your accrediting organization or licensing board for their acceptance of this CE activity.
Participation Costs
There is no cost to participate in this program.
This continuing education activity is active starting 24th November 2025 and will expire on 24th November 2025. Estimated time to complete this activity: 45 minutes.